ArticleTherapeutics and clinical risk management2022

Drug-Related Problems in Pulmonary Hypertension with Valvular Heart Disease.

Farizan Abdul-Ghaffar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.